Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000690·IRONWOOD PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
Common Stock · CUSIP: 46333X108
Event date: 2025-06-30
- Filing-level shares
- 16,202,129
- Percent of class
- 10.01%
- The Vanguard Group
Shares: 16,202,129 · Class: 10.01%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000690
- Form type
- SCHEDULE 13G/A
- Filer
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK 1446847
- Filed
- Jul 07, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership